Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Das Gupta

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Indian Journal of Medical Research|August 1, 1989
Limitations of the therapeutic regimens for myelodysplastic syndromeS H Advani, N K Giri, M G Dole, et al.
Acta Haematologica|January 1, 1988
Sudan black B positivity in acute lymphoblastic leukemiaB S Charak, S H Advani, S M Karandikar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2018
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR studyS Novello, J Mazières, I-J Oh, et al.
Journal of Intellectual Disability Research : JIDR|March 3, 2009
Brief report: Aggressive challenging behaviour in adults with intellectual disability following community resettlementS Bhaumik, J M Watson, J Devapriam, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Indian Journal of Medical Research|August 1, 1989
Limitations of the therapeutic regimens for myelodysplastic syndromeS H Advani, N K Giri, M G Dole, et al.
Acta Haematologica|January 1, 1988
Sudan black B positivity in acute lymphoblastic leukemiaB S Charak, S H Advani, S M Karandikar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2018
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR studyS Novello, J Mazières, I-J Oh, et al.
Journal of Intellectual Disability Research : JIDR|March 3, 2009
Brief report: Aggressive challenging behaviour in adults with intellectual disability following community resettlementS Bhaumik, J M Watson, J Devapriam, et al.
Pageof 5